Molecular Targeting Technologies, Inc. requests that their press release NewsItemId: 20251013226693 issued Oct 10, 2025 “Molecular Targeting Technologies, Inc. Initiates Legal Action Over Unauthorized Use of Albumin-binding Evans blue (EB) Targeted Radiotherapeutic (EB-TRT)” be killed.
The release was issued prematurely by Molecular Targeting Technologies, Inc.
A replacement release will be reissued on Tuesday, Oct. 14th.
Contacts
Chris Pak, Email: cpak@mtarget.com
